Order Article Reprints

den Brok MH, de Roode KE, Zijlmans LHM, Kleijn LHJ, van Stevendaal MHME, Versteegen RM, Wouters LWM, Rossin R, Robillard MS. Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug. Pharmaceuticals. 2025; 18(9):1380. https://doi.org/10.3390/ph18091380

den Brok, Martijn H., Kim E. de Roode, Luc H. M. Zijlmans, Laurens H. J. Kleijn, Marleen H. M. E. van Stevendaal, Ron M. Versteegen, Lieke W. M. Wouters, Raffaella Rossin, and Marc S. Robillard. 2025. "Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug" Pharmaceuticals 18, no. 9: 1380. https://doi.org/10.3390/ph18091380

den Brok, M. H., de Roode, K. E., Zijlmans, L. H. M., Kleijn, L. H. J., van Stevendaal, M. H. M. E., Versteegen, R. M., Wouters, L. W. M., Rossin, R., & Robillard, M. S. (2025). Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug. Pharmaceuticals, 18(9), 1380. https://doi.org/10.3390/ph18091380